Note: Ingredients listed on restricted chemical lists
EC/CAS
14464-46-1
Name of the chemical
Cristobalit (s. u. TRGS 906)
Concentration
N/A
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
N/A
General Information
Revision date
2024-09-11
Product name
Rescoweld S
1.2.1 Relevant identified uses
Refractory
supplier name
Resco Products, Inc
Emergency telephone
1-800-424-9300, +1 703-741-5970
Icons in SDS
Company Information
company name
Resco Products, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@RescoProducts.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H320, H350
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture GHS US classification Skin corrosion/irritation Category 2 H315 Causes skin irritation Serious eye damage/eye irritation Category 2B H320 Causes eye irritation Carcinogenicity Category 1A H350 May cause cancer (Inhalation) Full text of H statements see section 16
2.2 Label elements
GHS US labeling
Signal word
Danger
Hazard statements
H350 - May cause cancer (Inhalation) H320 - Causes eye irritation H315 - Causes skin irritation
Precautionary statements
P260 - Do not breathe dust. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P280 - Wear Respiratory Protection, protective gloves, eye protection, In case of insufficient ventilation, wear suitable respiratory equipment.
Other hazards which do not result in classification
Dust may form explosive mixture in air.
Ingredient(s) with unknown acute toxicity
No additional information available
2.1 Classification of the substance or mixture
GHS US classification Skin corrosion/irritation Category 2 H315 Causes skin irritation Serious eye damage/eye irritation Category 2B H320 Causes eye irritation Carcinogenicity Category 1A H350 May cause cancer (Inhalation) Full text of H statements : see section 16
